1 / 6

Point of Care/Rapid Diagnostic Market – Analysis and Forecast (2021-2027)

The mounting occurrence of infectious diseases, budding government support, mounting occurrence of target diseases, technological improvements and innovative product launches and boosting use of home-based POC devices are the primary growth drivers for point of care/rapid diagnostic market.<br><br>In addition, mounting amount of regulatory sanctions for innovative immunoassay techniques, expanding amount of clia-waived POC tests and lack of trained laboratory technicians are also driving the growth of the market.

Research1
Download Presentation

Point of Care/Rapid Diagnostic Market – Analysis and Forecast (2021-2027)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Point of Care/Rapid Diagnostic Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Point of Care/Rapid Diagnostic Market Point of care diagnostic allows diagnoses in the remote setting, home, physician’s office, or in the hospital. The outcomes of diagnosis are rapid, and allow speedy treatment to the patient. The global point of care/rapid diagnostic market is growing at significant rate, due to mounting occurrence of infectious diseases and technological improvements and innovative product launches. Different products contributed to the point of care/rapid diagnostic market size. The market has witnessed high demand for infectious disease testing over the last few years due escalating accessibility and alertness about infectious disease POC testing products. The mounting occurrence of infectious diseases, budding government support, mounting occurrence of target diseases, technological improvements and innovative product launches and boosting use of home-based POC devices are the primary growth drivers for point of care/rapid diagnostic market. In addition, mounting amount of regulatory sanctions for innovative immunoassay techniques, expanding amount of clia-waived POC tests and lack of trained laboratory technicians are also driving the growth of the market.

  4. Global Point of Care/Rapid Diagnostic Market Healthcare decentralization, expanding number of conferences and events and POC tests with multiplexing competences are also facilitating the growth for the point of care/rapid diagnostic market. Geographically, North America is the largest point of care/rapid diagnostic market as in the region the occurrence of lifestyle associated diseases is increasing. Mounting number of product approvals and expanding government schemes are also up surging growth of the North American point of care/rapid diagnostic market. Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of lifestyle associated diseases, budding government initiatives, and escalating occurrence of infectious disease are also creating a positive impact on the point of care/rapid diagnostic market growth in the region.

  5. Global Point of Care/Rapid Diagnostic Market • Key players in the point of care/rapid diagnostic market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, Abbott received FDA clearance for the Afinion HbA1c diagnostic assay for identifying patients at risk of diabetes and diagnosing diabetes. • Abbott Laboratories, Danaher Corporation, Accubiotech, Johnson & Johnson, Becton, Dickinson, and Company, EKF Diagnostics, Nova Biomedical, Quidel, Roche Diagnostics, Chembio Diagnostics, PTS Diagnostics and Instrumentation Laboratory are the key players offering point of care/rapid diagnostic.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/point-of-carerapid-diagnostic-market/request-sample www.vynzresearch.com

More Related